论文信息 - Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.

[1] H. Fox,et al. TREATMENT OF ULCERATIVE COLITIS WITH ORAL DISODIUM CROMOGLYCATE A Double-blind Controlled Trial , 1976, The Lancet.

[2] B. Evans,et al. Disodium cromoglycate in the treatment of chronic proctitis. , 1975, Acta allergologica.

[3] J. H. Baron,et al. Variation Between Observers in Describing Mucosal Appearances in Proctocolitis* , 1964, British medical journal.

[4] W. Cooke,et al. The clinical significance of seromucoids in regional ileitis and ulcerative colitis. , 1958, Gastroenterology.

[5] B. Morson. The technique and interpretation of rectal biopsies in inflammatory bowel disease. , 1974, Pathology annual.

[6] Morson Bc. The technique and interpretation of rectal biopsies in inflammatory bowel disease. , 1974 .